[1]
A. Yadav, S. Chander, H. Lathiya, H. Sharma, K. Goyal, and M. Sankaranarayanan, “De novo design and in-silico studies of novel bis-arylpiperazine derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase”, J Pharm Chem, vol. 1, no. 2, pp. 22–27, Jul. 2014, doi: 10.14805/jphchem.2014.art10.